The Awards are particularly focused on helping people with cancer types that are known to harbor rare genomic alterations and which may benefit from tumor testing.
Programs may be relevant to pediatric or adult cancer communities.
Two grants are being offered in 2021 – one for $50,000 and a second for $25,000. Successful applications will be chosen by an independent Review Panel, comprised of leading experts from the clinical and patient advocacy cancer community.
Applicants can apply to support a new initiative or to support continued rollout/expansion of an existing program. Applying for the grant does not preclude organizations from seeking other sources of funding. Bayer will make every effort to help successful applicants share their programs with the wider cancer community, read more.